Saxenda is liraglutide, a once-daily GLP-1 injection Novo Nordisk sells for chronic weight management. Its diabetes sibling, Victoza, is the same molecule at lower doses. Both come in 18 mg/3 mL prefilled pens, and both are now unusual in the GLP-1 world for one reason: they have real generic competition.
Every other GLP-1 on the US market (semaglutide, tirzepatide) is still brand-only, which is why manufacturer self-pay programs are the whole story on those drugs. Liraglutide lost exclusivity, generics launched, and the cash price collapsed. This guide covers what generic liraglutide, brand Saxenda, and Victoza actually cost as verified on August 31, 2026, plus why Novo’s own savings program is no longer an option here.
What Does Saxenda Cost Without Insurance?
Retail figures come from SingleCare’s live drug pages for liraglutide, Saxenda, and Victoza, all showing prices updated August 31, 2026. The list price comes from Novo Nordisk’s own page.
| Option | Low | Average | High |
|---|---|---|---|
| Generic liraglutide, 2 pens, with a discount card | $104.90 (CVS) | $224.26 (Walgreens) | $499.69 (Walmart Neighborhood Market) |
| Generic liraglutide, 2 pens, no card | $795.68 | $795.68 | $795.68 |
| Generic liraglutide, 5-pen month, card price | ~$262 | ~$262 | ~$262 |
| Brand Saxenda, 5-pen carton, with a discount card | $650.75 ($130.15/pen at CVS) | $876.65 ($175.33/pen at Walgreens) | $1,157.90 ($231.58/pen at Kroger) |
| Brand Saxenda, 5-pen carton, no card | $1,898.74 | $1,898.74 | $1,898.74 |
| Brand Victoza, 3 pens, no card | $1,403.28 | $1,403.28 | $1,403.28 |
| Novo Nordisk list price, Saxenda | $1,349.02 | $1,349.02 | $1,349.02 |
The five-pen figures are the two-pen and one-pen prices scaled up, since SingleCare quotes liraglutide by the pen and Saxenda cartons ship five at a time. Note that Novo’s published Saxenda list price ($1,349.02) sits well below SingleCare’s average retail for a five-pen carton ($1,898.74). Sources differ here, and the gap is normal: list price is what the manufacturer sets before the supply chain marks it up, not what a cash payer is quoted at the register.
The generic is the headline
Liraglutide is the only GLP-1 where the generic route exists at all. FDA’s own first-generics list records ANDA 215503, liraglutide injection from Hikma Pharmaceuticals USA, approved December 23, 2024, referencing Victoza. Teva then announced FDA approval and US launch of a generic version of Saxenda on August 28, 2025, calling it the first generic GLP-1 indicated for weight loss.
The practical effect is visible in the price table. The same 18 mg/3 mL pen costs about $52 with a discount card as a generic and about $130 to $232 with a discount card as brand Saxenda. Over a five-pen month, that is roughly $262 versus $651 to $1,158.
Saxenda’s manufacturer program is gone
This is the trap on this drug. Novo Nordisk’s Saxenda page states that the Saxenda Savings Offer program was discontinued for new enrollees as of June 30, 2023. There is also no Saxenda self-pay price inside NovoCare Pharmacy the way there is for Wegovy and Ozempic.
So the standard GLP-1 playbook of “go straight to the manufacturer” does not work here. On Saxenda, the manufacturer route is the expensive route, and the discount card on the generic is the cheap one. That is the reverse of every other drug in this class.
What Drives the Price
Brand versus generic. This is the single biggest lever, worth roughly $400 to $900 a month at five-pen quantities based on the August 2026 SingleCare data. Nothing else on this page moves the number that much.
How many pens your month takes. Liraglutide is a daily injection and the pens are priced individually, so a Victoza-level prescription (two to three pens) and a Saxenda-level one (five pens) are very different monthly bills for identical pens.
The specific pharmacy. SingleCare’s generic liraglutide data spans $104.90 at CVS to $499.69 at Walmart Neighborhood Market for the same two pens. That is a nearly fivefold spread inside one discount card, which is unusually wide even for generics.
Which discount card you use. Cards negotiate independently, so the cheapest card at one chain is often not the cheapest at another. This is a two-minute check, not a research project.
Brand indication. Saxenda (weight management) and Victoza (type 2 diabetes) are the same molecule at different dose ceilings, and they are priced differently. SingleCare’s August 2026 pages show brand Victoza at $1,403.28 average cash for three pens and brand Saxenda at $1,898.74 for five, while the generic is quoted off a single per-pen price regardless of which brand it references. That is why the generic sidesteps the indication question entirely on price.
Region. All of the figures above are national averages built from chain pricing. Independent pharmacies and rural markets routinely land outside that band in both directions, so treat the table as a starting point for negotiation rather than a fixed rate.
Cash Price vs. Insurance
Weight-management drugs are the most commonly excluded category in commercial benefit design, so many people with insurance still end up paying cash for Saxenda. Victoza, as a diabetes drug, is covered far more often.
Because Novo retired the Saxenda savings offer for new enrollees, there is no manufacturer card to fall back on if your plan denies coverage. That makes the cash comparison unusually simple: if the drug is excluded, price the generic with a discount card and compare it against your plan’s price for the brand. Discount-card prices cannot be combined with insurance on the same fill, so it is one or the other.
One more wrinkle worth knowing: cash and discount-card spending generally does not count toward your deductible or out-of-pocket maximum. If you expect to hit your deductible this year anyway, running the brand through insurance may be worth more than it looks on a single fill. If you never come close, cash on the generic wins easily. Our fair price checker is a fast way to test whatever number a pharmacy quotes you.
How to Pay Less
-
Ask for generic liraglutide by name. This is the whole ballgame. Prescriptions written for the brand are not always auto-substituted, and at SingleCare’s August 2026 prices the generic saves roughly $400 to $900 a month at five-pen quantities.
-
Run the same prescription through two discount cards at three pharmacies. The generic swings from $104.90 to $499.69 for two pens depending on where you fill it. Our guide to GoodRx vs. SingleCare walks through checking both on one drug.
-
Check the direct-to-consumer pharmacies too. Mark Cuban’s Cost Plus Drugs publishes a per-pen price for liraglutide 18 mg/3 mL on its own drug page with the manufacturing cost, markup, and pharmacy fee broken out. Prices there change, so pull the current figure before you commit.
-
Apply for patient assistance if you have Medicare or no insurance. The Novo Nordisk Patient Assistance Program provides medicine at no cost to approved applicants who meet income limits, generally at or below 400% of the federal poverty level for most products. Novo notes some medicines left the program for 2026, so confirm the current product list before applying.
-
Get the prescribing visit somewhere cheap. A free or sliding-scale clinic can handle the visit and the refills at little or no cost, which matters on a drug that needs ongoing follow-up.
-
If a bill already got away from you, negotiate it. Pharmacy bills are less negotiable than facility bills, but if a clinic or infusion center billed you for the visit side of this, the tactics in how to negotiate medical bills apply directly.
Bottom Line
Budget roughly $262 a month for generic liraglutide at five-pen quantities with a discount card, and about $1,899 a month for brand Saxenda at average cash price. That is the widest brand-to-generic gap anywhere in the GLP-1 class, and it exists only because liraglutide lost exclusivity while every other GLP-1 has not.
Do not go looking for a Novo savings card on this one. It was discontinued for new enrollees in 2023, and the generic beats what the card ever offered. If you are weighing liraglutide against the newer options, our GLP-1 cost guide compares every brand’s self-pay price, and the individual guides to Wegovy, Mounjaro, and Rybelsus cover their programs in detail. If you take insulin alongside this, the $35 insulin programs are worth checking on the same trip.